Read more on Biosimilar Interchangeability Requirements and Pharmacist Resources
AMCP and the AMCP Foundation are pleased to announce winners of this year’s awards that recognize individuals who have made significant contributions to the organizations and managed care pharmacy. The awards are presented annually in the spring.
Christina Barrington, PharmD, vice president and chief pharmacy officer at Priority Health, a nationally recognized nonprofit health plan serving more than 1.3 million members, has been sworn in as president of the Board of Directors for the Academy of Managed Care Pharmacy (AMCP) for 2024-2025.
The Academy of Managed Care Pharmacy (AMCP) today launched the AMCP Research Institute (ARI), a research-based resource that will conduct and facilitate projects important to the mission of managed care pharmacy. Incorporating AMCP’s existing Biologics & Biosimilars Collective Intelligence Consortium (BBCIC), the ARI will expand the scope of research opportunities for AMCP, thereby helping to advance the larger goal of improving public health in the United States.
Health economic modeling platform to support clinical and economic value information exchange between manufacturers and payers.
AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship and selects Daria Sinclair of Howard University to be the first Health Disparities Research Intern.
AMCP has chosen Iulia Opran, a PharmD/MS candidate, as its 2024–2025 Executive Fellow in Health Care Association Leadership. Her diverse pharmacy background and passion for managed care make her a valuable addition to the program, which begins on July 1, 2024.
As part of AMCP Foundation's efforts to train managed care pharmacists in specialized care practices, Raquel Erb, a PharmD candidate at the University of Texas at Austin, College of Pharmacy, completed our inaugural internship sponsored by Sanofi, studying and optimizing the benefit design of specialty drugs.
The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) today announced that it has been awarded a $1.4 million grant from the Food & Drug Administration (FDA) to enable biosimilar research.
AMCP applauds the 10th Circuit for protecting the vital functions of ERISA & Medicare Part D, which provide essential services to workers and seniors, in yesterday’s ruling in the case of @PCMA v. Glen Mulready.
The AMCP Format public comment period facilitates an exchange of information between manufacturers and health care decision-makers to inform formulary and coverage decisions.
AMCP issued the following statement regarding the Supreme Court’s April 21 order.